Erythropoietin requirement in patients with type 2 diabetes mellitus on maintenance hemodialysis therapy

Wiener Klinische Wochenschrift

Volumn 116, Issue 24, 2004, Pages 844-848

  Biesenbach, Georg ^a   Schmekal, Bernhard ^a   Eichbauer Sturm, Gabriela ^a   Janko, Otmar ^a  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Chronic hemodialysis; Diabetic patients; Erythropoietin requirement

Indexed keywords

C REACTIVE PROTEIN; CYANOCOBALAMIN; ERYTHROPOIETIN; FERRITIN; FOLIC ACID; HEMOGLOBIN; IRON; IRON SACCHARATE; TRANSFERRIN;

ADULT; AGED; ANEMIA; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE SEVERITY; DRUG DOSE REGIMEN; EVALUATION; FEMALE; FERRITIN BLOOD LEVEL; FOLIC ACID BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; INFECTION; IRON THERAPY; KIDNEY FAILURE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; RISK FACTOR; VITAMIN BLOOD LEVEL;

ADULT; AGED; C-REACTIVE PROTEIN; CHI-SQUARE DISTRIBUTION; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; ERYTHROPOIETIN; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROSPECTIVE STUDIES; RENAL DIALYSIS; TIME FACTORS; TRANSFERRIN;

EID: 12344262872     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-004-0286-7     Document Type: Article

References (25)

1. Valderrabano F (1996) Erythropoietin in chronic renal failure. Kidney Int 50: 1373-1391
2. Schäfer R (2002) Advances in therapy of renal anemia: darbepoetin alpha. Wien Klin Wochenschr 114: 955-957
3. Bosman DR, Winkler AS, Marsden JT, Macdougal IC, Watkins P (2001) Anemia with erythropoietin occurs early in diabetic nephropathy. Diabetes Care 24: 495-499
4. Ishimura E, Nishizawa Y, Okuno S, Matsumoto N, Emoto M, Inaba M, Kawagishi T, Kim CW, Morii H (1998) Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. J Nephrol 11: 83-86
5. Ghirlanda G, Cotroneo P, Todaro L, Pitocco D, Manto A, Storti S, Caputo S, Ricerca BM (2000) Erythropoietin response to anemia in patients with type 1 diabetes. Diabet Med 17: 410
6. Koijima K, Totsuka Y (1995) Anemia due to reduced serum erythropoietin concentrations in non-uremic diabetic patients. Diabetes Res Clin Pract 27: 229-233
7. Ifudu O, Uribarri J, Rajwani I, Vlacich V, Reydel K, Delosreyes G, Friedman A (2001) Gender modulates responsiveness to recombinant erythropoietin. Am J Kidney Dis 38: 518-522
8. Hörl WH, Holzer H, Mayer GJ; Österreichische Aranesp Studiengruppe (2002) Treatment of renal anemia with darbepoetin alpha: results of an Austrian multicenter study. Wien Klin Wochenschr 114: 967-971
9. Weiss G (2002) Iron, infection and anemia - a classical triade. Wien Klin Wochenschr 114: 357-367
10. Kosch M, Schäfer RM (2001) Neue Aspekte der adjuvanten Eisentherapie. Nieren- und Hochdruckkrankh 30: 84-90
11. Fishbane S, Frei GL, Maesaka J (1995) Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation. Am J Kidney Dis 26: 41-46
12. Drüeke TB, Barany P, Cazzola M, Eschbach JW, Grützmacher P, Kaltwasser JP, Macdougal IC, Pippard MJ, Shaldon S, van Wyck D (1997) Management of iron deficiency in renal anemia: guidelines for the optimal approach in erythropoietin-treated patients. Clin Nephrology 48: 1-8
13. European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure (1999) Nephrol Dial Transplant 14 [Suppl 5]: 1-8
14. Jahn CH (1993) Relation of serum erythropoietin concentration to erythropoiesis in different chronic kidney diseases and stages of kidney failure. Wien Klin Wochenschr 105: 327-329
15. Cotroneo P, Maria Ricerca B, Todaro L, Pitocco D, Manto A, Ruotolo V, Storti S, Damiani P, Caputo S, Ghirlando G (2000) Blunted erythropoietin response to anemia in patients with typel diabetes. Diabetes Metab Res Rev 16: 172-176
16. Jassal SV, Douglas JF, Stout RW (1998) Prevalence of central autonomic neuropathy in elderly dialysis patients. Nephrol Dial Transplant 13: 1702-1708
17. Rarick MU, Espina BM, Colley DT, Chrusoski Am Gandara S, Feinstein DI (1998) Treatment of a unique anemia in patients with IDDM with epoetin alfa. Diabetes Care 21: 423-426
18. Winkler AS, Marsden J, Chaudhuri KR, Hambley H, Watkins P (1999) Erythropoietin depletion and anemia in diabetes mellitus. Diabet Med 16: 813-819
19. Yun YS, Lee HC, Yoo NC, Song YD, Lim SK, Kim KR, Hahn JS, Huh KB (1999) Reduced erythropoietin responsiveness to anemia in diabetic patients before advanced diabetic nephropathy. Diabetes Res Clin Pract 46: 223-229
20. Means RT, Krantz S (1992) Progress in understanding the pathogenesis of the anemia of chronic disease. Blood 80: 1639-1647
21. Macdougall IC (1995) Poor response to erythropoietin: practical guidelines on investigation and management. Nephrol Dial Transpl 10: 607-614
22. Eckardt KU (2002) Anemia in critical illness. Wien Klin Wochenschr 113: 84-89
23. Hacking CM, Beerenhout CM, Hermans M, Van der Kuy PH, Van der Dussen H, Dieijen-Visser MP, Hamulyak K, Van der Sande FM, Leunissen KM, Kooman JP (2004) The relationship between reticulocyte hemoglobin content with C-reactive protein and conventional iron parameters in dialysis patients. J Nephrology 17: 107-111
24. Thomas C, Thomas L (2001) Biochemical markers and hematologic indices in the diagnosis of functional deficiency. Clin Chem 48: 981-982
25. Abu-Alfa AK, Cruz D, Perazella MA, Mahnensmith RL, Simon D, Bia MJ (2000) ACE inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients. Am J Kidney Dis 35: 1076-1082